Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-Up, Noncompliance, and Stratification
- 1 September 1986
- journal article
- research article
- Published by JSTOR in Biometrics
- Vol. 42 (3) , 507-519
- https://doi.org/10.2307/2531201
Abstract
When designing a clinical trial to test the equality of survival distributions for two treatment groups, the usual assumptions are exponential survival, uniform patient entry, full compliance, and censoring only administratively at the end of the trial. Various authors have presented methods for estimation of sample size or power under these assumptions, some of which allow for an R-year accrual period with T total years of study, T > R. The method of Lachin (1981, Controlled Clinical Trials 2, 93-113) is extended to allow for cases where patients enter the trial in a nonuniform manner over time, patients may exit from the trial due to loss to follow-up (other than administrative), other patients may continue follow-up although failing to comply with the treatment regimen, and a stratified analysis may be planned according to one or more prognostic covariates.This publication has 7 references indexed in Scilit:
- Applicability of sample size calculations based on a comparison of proportions for use with the logrank testControlled Clinical Trials, 1985
- Consideration of covariates and stratification in sample size determination for survival time studiesJournal of Chronic Diseases, 1985
- Relative efficiency in survival analysisJournal of Chronic Diseases, 1983
- Sample size requirements for comparing time-to-failure among k treatment groupsJournal of Chronic Diseases, 1982
- Introduction to sample size determination and power analysis for clinical trialsControlled Clinical Trials, 1981
- Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observationJournal of Chronic Diseases, 1981
- Planning the size of a cohort study in the presence of both losses to follow-up and non-complianceJournal of Chronic Diseases, 1980